Cardiovascular diseases are a leading cause of death worldwide posing a major challenge to public health systems. Given the obvious need for medical advances, they are among the most extensively studied fields in clinical trials. The field also has a long history of significant scientific breakthroughs that have shaped modern medicine.
We have extensive experience in cardiovascular research. Over the years, we have worked with a wide range of patient populations from heart failure and atrial fibrillation to the prevention of hypertension and coronary artery disease. We also have the capacity to conduct trials involving cerebrovascular disease and peripheral arteriosclerosis obliterans (ASO). Versatility is at the core of what we do: we can combine different patient populations and adapt our service offering to meet the specific needs of each trial protocol.
While our research team brings extensive scientific and clinical experience in treating patients with cardiovascular diseases, we also place high value on collaboration with different medical specialities, such as cardiology. In cardiovascular research, we work closely with cardiologists to incorporate examinations such as cardiac ultrasonography into our clinical trials. Additional procedures may include imaging and body composition analysis.
We are here to advance your therapeutic breakthroughs with extensive scientific and clinical experience, always adhering to Good Clinical Practice (GCP).
Contact usClinical trials are our core business and top priority—and we ensure they are always supported with dedicated, expert resources. Please see below for our ongoing and previous clinical trials.
A large international multicenter study of a novel weight loss medication for the prevention of cardiovascular disease in individuals with excess body weight and established cardiovascular disease
A large international multicenter study of a novel weight loss medication in individuals with excess body weight
A large international multicenter study of a novel inflammation-lowering medication on heart failure outcomes in individuals with heart failure and low-grade inflammation
A large international multicenter study of a novel weight loss medication in individuals with excess body weight and type 2 diabetes
A large international multicenter study of a novel weight loss medication in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication for the prevention of cardiovascular events in individuals with established cardiovascular disease
A large international multicenter study of two weight loss medications in individuals with excess body weight
A large international multicenter study of a weight loss medication and long-acting insulin on glucose management in individuals with type 2 diabetes
A large international multicenter study of a novel anticoagulant for the prevention of stroke in individuals with atrial fibrillation
A large international multicenter study of a weight loss medication on the incidence of cardiovascular disease in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk
A large international multicenter study of a cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk